Skip to main content
NIH funding notice RFA-DK-18-007

Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)

Closed on April 11, 2019.

Posted
January 23, 2019
Close date
April 11, 2019
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $735,208 in first-year total cost, median $367,604.

Most frequent study sections

  1. Special Emphasis Panel[ZDK1 GRB-1 (O3)]2

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA AT DAVIS1
  2. VANDERBILT UNIVERSITY MEDICAL CENTER1
Competing awards under RFA-DK-18-007 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2019Identifying Modifiable Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes1U34DK123895-01JASER, SARAH SANDERSJORDAN, LORI CHAFFINVANDERBILT UNIVERSITY MEDICAL CENTER, TN$368,706ZDK1
2019Planning for a Cohort Study on Neurocognitive Complication of Type 1 Diabetes in Children1U34DK123894-01GHETTI, SIMONAGLASER, NICOLE SUNIVERSITY OF CALIFORNIA AT DAVIS, CA$366,502ZDK1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.